AK119, A CD73 TARGETING ANTIBODY WITH DUAL MECHANISM OF ACTION

被引：1
|
作者：
Huang, Zhaoliang [1 ]
Pang, Xinghua [2 ]
Zhong, Tingting [2 ]
Jin, Chunshan [2 ]
Chen, Na [2 ]
He, Xinrong [2 ]
Xia, Dennis [2 ]
Jin, Xiaoping [3 ]
Wang, Zhongmin [2 ]
Xia, Xu [2 ]
Li, Baiyong [2 ]
机构：
[1] Akeso Bliopharma Inc, Zhongshan, Peoples R China
[2] Akeso Biopharma Inc, Zhongshan, Peoples R China
[3] Akeso Biopharma Inc, Potomac, MD USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.750
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
750
引用
收藏
页码：A783 / A784
页数：2
相关论文
共 50 条
  • [41] SELECTION OF APTAMERS TARGETING CD73 BY USING CAPILLARY ELECTROPHORESIS-BASED PROTOCOLS.
    Cheffer, A.
    Mueller, C. E.
    Ulrich, H.
    PURINERGIC SIGNALLING, 2018, 14 : S103 - S104
  • [42] Identification of allosteric inhibitors of the ecto-5′-nucleotidase (CD73) targeting the dimer interface
    Rahimova, Rahila
    Fontanel, Simon
    Lionne, Corinne
    Jordheim, Lars Peter
    Peyrottes, Suzanne
    Chaloin, Laurent
    PLOS COMPUTATIONAL BIOLOGY, 2018, 14 (01)
  • [43] CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
    Turcotte, Martin
    Allard, David
    Mittal, Deepak
    Bareche, Yacine
    Buisseret, Laurence
    Jose, Vinu
    Pommey, Sandra
    Delisle, Vincent
    Loi, Sherene
    Joensuu, Heikki
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Sotiriou, Christos
    Smyth, Mark J.
    Stagg, John
    CANCER RESEARCH, 2017, 77 (20) : 5652 - 5663
  • [44] PHARMACOKINETICS AND PHARMACODYNAMICS OF GS-1423, A FIRST-IN-CLASS BIFUNCTIONAL ANTIBODY TARGETING CD73 AND TGFB, IN SUBJECTS WITH ADVANCED TUMORS.
    Hsueh, C.
    Zavodovskaya, M.
    Tarnowski, T.
    Tolcher, A.
    Gordon, M.
    Strauss, J.
    Ma-Honey, K.
    Juergensmeier, J.
    Chen, T.
    Othman, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S25 - S25
  • [45] MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73
    Minghao Xie
    Huabo Qin
    Qianxin Luo
    Qunsheng Huang
    Xiaosheng He
    Zihuan Yang
    Ping Lan
    Lei Lian
    BMC Cancer, 17
  • [46] CD73 targeting therapy enhances the anti-tumor effect of radiation therapy in rectal cancer
    Tsukui, Hidenori
    Horie, Hisanaga
    Saito, Akira
    Koinuma, Koji
    Ohsawa, Hideyuki
    Yamaguchi, Hironori
    Sakuma, Yasunaru
    Hosoya, Yoshinori
    Yoshimura, Kotaro
    Lefor, Alan
    Sata, Naohiro
    Kitayama, Joji
    CANCER RESEARCH, 2020, 80 (16)
  • [47] Transplantation of human iPSC-derived photoreceptor precursors isolated by targeting of the surface antigen CD73
    Gagliardi, Giuliana
    Ben M'Barek, Karim
    Conart, Jean-Baptiste
    Slembrouck-Brec, Amelie
    Degardin, Julie
    Nanteau, Celine
    Reichman, Sacha
    Goureau, Olivier
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [48] Therapeutic targeting of HIF-1 alpha induced CD73 expression in experimental esophageal adenocarcinoma
    Hassan, Md Sazzad
    Ali, Aktar
    Ponna, Saisantosh
    Scofield, Dimitri
    Awasthi, Niranjan
    Jantz, Mark
    von Holzen, Urs
    CANCER RESEARCH, 2023, 83 (07)
  • [49] MEDI9447: enhancing anti-tumor immunity by targeting CD73 In the tumor microenvironment
    Hay, Carl
    Sult, Erin
    Huang, Qihui
    Hammond, Scott
    Mulgrew, Kathy
    McGlinchey, Kelly
    Fuhrmann, Stacy
    Rothstein, Raymond
    Poon, Edmund
    Stewart, Ross
    Hollingsworth, Robert
    Sachsenmeier, Kris
    CANCER RESEARCH, 2015, 75
  • [50] Discovery and characterization of new original blocking antibodies targeting the CD73 immune checkpoint for cancer immunotherapy
    Paoli, Marc Giraudon
    Augier, Severine
    Blemont, Marilyne Royannez
    Rodriguez, Celine
    Blanc, Helene Rispaud
    Chanteux, Stephanie
    Gourdin, Nicolas
    Gauthier, Laurent
    Caux, Christine Menetrier
    Morel, Yannis
    Caux, Christophe
    Paturel, Carine
    Perrot, Ivan
    CANCER RESEARCH, 2016, 76
12345